Table 2

Randomized Clinical Trials to Prevent Depression in Primary Care

Author, Year CountryTarget Population, Type of PreventionInclusion CriteriaSample (Control/Intervention) No.Care ManagementIntervention Orientation (No. of Sessions/Format)ClinicianMain OutcomeFollow-upRisk of Biasa
Barrett et al,49 2001b (United States)Adults (18–59 y)
Indicatedc
Minor depression (HRSD ≥10; PRIME-MD)74 (38/36)1. PST-PC
2. Placebo plus clinical management
CB (6/individual)PsychologistsDepressive symptoms (HSCL-D-20 depression scale)11 wk1 (llulll)
Bellón et al,47 2016 (Spain)Adults (18–75 y)
Universald
No MD in past 6 mo (CIDI)3,326 (1,663/1,663)1. Biopsychosocial intervention
2. CAU
Biopsychosocial personalized (3/individual)Primary care physicians who received a 10- to 15-h training workshopIncidence MD (CIDI)6-12-18 mo2 (llhlll)
Brugha et al,44 2011 (United Kingdom)Women postnatally
Selectivee
No depression (EPDS <12)2,241 (767/1,474)1. CBA/PCA
2. CAU
CBA/PCA (8/individual)Community nurse (health visitor) with 6 half-days training and access to regular supervision sessionsProportion of women scoring ≥12 EPDS6-12-18 mo5 (luhhll)
Brugha et al,45 2016 (United Kingdom)Pregnant women
Selectivee
No depression (EPDS <12)186 (83/103)1. CBA
2. CAU
CBA (3/individual)Community midwife with 8-d training in psychological care (1 d exclusively in the use of the EPDS)Proportion of women scoring ≥12 EPDS22 wk4 (llhlhl)
Frank et al,38 2002b (United States)Adults (≥18 y)
Indicatedc
Minor depression (HRSD ≥10; PRIME-MD)168 (89/79)1. PST-PC
2. Placebo plus clinical management
CB (6/individual)Psychologists, social workers, counselorsDepressive symptoms (HSCL-D-20 depression scale)11 wk3 (llulhl)
García-Campayo et al,43 2010 (Spain)Adults (18–65 y)
Selectivee
No DSM-IV Axis I psychiatric disorders (SPPI)104 (52/52)1. Psychoeducational
2. No intervention
Psychoeducational and CB (5/group)Primary care physicians with specific training in mental health and group therapyPrevalence of somatoform disorders (SPPI)3-6-60 mo3 (llhlul)
Gillham et al,40 2006 (United States)Early adolescents (11–12 y)
Indicatedc
No MD (CDI ≥7/9; DICA-R)271 (124/147)1. CBT (PRP)
2. CAU
CB (12/group)Child psychologists, child social workersDepressive symptoms (CDI)6-12-18-24 mo7 (lhhhul)
González et al,50 2006 (Spain)Adults (25–55 y)
Indicatedc
No depressive disorder (DSM-IV)60 (NR/NR)1. CBT
2. Encouraging personal resources
3. Social support
4. Waiting list
CB (6/group)PsychologistsDepressive symptoms (BDI)6-12 mo9 (uhhhhl)
Lynch et al,37 1997 (United States)Adults (≥18 y)
Indicatedc
Minor depression (MOS Depression Screening Inventory >cutoff; DIS)29 (14/15)1. PST
2. CAU
CB (6/individual by telephone)Student therapist, medical student, graduate nursing studentDepressive symptoms (BDI)7 wk7 (uhhlhl)
Muñoz et al,36 1993–1995 (United States)Adults (≥18 y)
Selectivee
No MD in past 6 months (DIS)150 (78/72)1. CBT
2. No intervention or information by videotape
CB (8/group)PsychologistsIncidence of depression (DIS), depressive symptoms (BDI, CES-D)6-12 mo2 (llhlll)
van’t Veer-Tazelaar et al,41,42 2009–2011f (the Netherlands)Elderly (≥75 y)
Indicatedc
Subthreshold depressive symptoms, no MDE (CES-D ≥16; MINI)170 (84/86)1. Stepped-care program
2. CAU
CB (10/individual)Home care nurse, specially trained (CBT-bibliotherapy), community psychiatric nurse (CBT + PST), primary care physician to give psychotropic medication (only for participants with continuously elevated CES-D scores)Cumulative incidence of MDD (MINI)6-12-24 mo4 (lhhlll)
Willemse et al,39 2004 (the Netherlands)Adults (18–65 y)
Indicatedc
Subthreshold depression, no MDD in past 12 mo (CIDI)216 (109/107)1. CBT
2. CAU
CB (CWD) (7/individual)Prevention specialist, clinician from a community mental health centerIncidence of depression (CIDI), depressive symptoms (CES-D)12 mo4 (lhhlll)
Williams et al,48 2000b (United States)Older adults (≥60 y)
Indicatedc
Minor depression (HRSD ≥10; PRIME-MD)130 (67/63)1. PST-PC
2. Placebo plus clinical management
CB (6/individual)Psychologists, social workers, counselorsDepressive symptoms (HSCL-D-20 depression scale)11 wk1 (llulll)
Zhang et al,46 2014f (China)Adults (≥18 y)
Indicatedc
Subthreshold depression, no MD (CES-D ≥16; SCID)240 (119/121)1. Stepped-care program
2. CAU
CB (12/individual)Social workers with at least 3 y counseling experience, primary care physician to give psychotropic medication (only for participants with continuously elevated CES-D scores) or referred to see a psychiatristIncidence MD (SCID), depressive symptoms (CES-D)3-6-9-12-15 mo3 (llhlul)
  • BDI = Beck Depression Inventory; CAU = care as usual; CB = cognitive behavioral; CBA = cognitive behavioral approach; CBT = cognitive behavioral therapy; CDI = Children’s Depression Inventory; CES-D = Center for Epidemiologic Studies of Depression; CIDI = Composite International Diagnostic Interview; DICA-R = Diagnostic Inventory for Children and Adolescents; DIS = Diagnostic Interview Schedule; DSM = Diagnostic and Statistical Manual of Mental Disorders; EPDS = Edinburgh Postnatal Depression Scale; HDRS = Hamilton Depression Rating Scale; HSCL-D = Hopkins Symptom Checklist for Depression; MD = major depression; MDD = major depressive disorder; MDE = major depressive episode; MINI = Mini International Neuropsychiatric Interview; MOS = Medical Outcome Study; NR = not reported; PCA = person centered approach; PRIME-MD = The Primary Care Evaluation of Mental Disorders; PRP = Penn Resiliency Program; PST = problem solving therapy; PST-PC = problem solving treatment for primary care; SCID = Structured Clinical Interview for DSM-IV; SPPI = Standardized Polyvalent Psychiatric Interview.

  • Note: CB, CBA, and CBT focus on the development of personal coping strategies that target solving current problems and changing unhelpful patterns in cognitions (eg, thoughts, beliefs, and attitudes), behaviors, and emotional regulation.

  • a High score means higher risk of bias. Low risk (l) = 0 points; unclear risk (u) = 1 point; or high risk (h) = 2 points; indicate rating of 6 quality criteria: random sequence, allocation concealment, blinding of participants and clinicians, blinding of outcome assessment, incomplete outcome data, selective reporting.

  • b These studies had 3 arms (paroxetine, placebo and problem-solving therapy), but we only used placebo vs problem-solving therapy.

  • c Patients with minor or subthreshold depression.

  • d General population.

  • e Patients with some risk factors for depression.

  • f In these studies, we collected only depression data.